Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
出版年份 2013 全文链接
标题
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 17, Issue 11, Pages 1371-1384
出版商
Wiley
发表日期
2013-11-20
DOI
10.1111/jcmm.12169
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT
- (2015) Barbara Nasilowska-Adamska et al. Annals of Transplantation
- Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer
- (2013) Saroj Vadhan-Raj ANNALS OF INTERNAL MEDICINE
- Melphalan 180 mg/m2 Can Be Safely Administered As Conditioning Regimen before an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Creatinine Clearance 60 mL/min/1.73 m2 or Lower with Use of Palifermin for Cytoprotection: Results of a Phase I Trial
- (2012) Muneer H. Abidi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase I Study of the Tolerability and Pharmacokinetics of Palifermin in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Ashok Srinivasan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function
- (2012) Muneer H. Abidi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden
- (2012) N Blijlevens et al. BONE MARROW TRANSPLANTATION
- Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial
- (2012) M H Jagasia et al. BONE MARROW TRANSPLANTATION
- Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
- (2012) J D Goldberg et al. BONE MARROW TRANSPLANTATION
- Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation
- (2011) Romee Rizwan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
- (2011) Quynh-Thu Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial
- (2011) Michael Henke et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer
- (2011) Wolfgang Schuette et al. Journal of Thoracic Oncology
- Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant
- (2011) Yi Wang et al. LEUKEMIA & LYMPHOMA
- A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma
- (2010) G. Kobbe et al. ANNALS OF ONCOLOGY
- Palifermin-induced acral erythrodysaesthesia variant in the treatment of acute myeloid leukaemia
- (2010) Olivia Milne et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- A Phase 1 Dose-Escalation Study To Evaluate The Safety And Pharmacokinetics Of Palifermin In Pediatric Subjects With Acute Leukemias Undergoing Myeloablative Therapy And Allogeneic Hematopoietic Stem Cell Transplant
- (2010) J. Morris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Evaluation of current and upcoming therapies in oral mucositis prevention
- (2010) Jerry C Wu et al. Future Oncology
- Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation
- (2009) R. M. Kelly et al. BLOOD
- Combination of radiotherapy and chemotherapy in locally advanced NSCLC
- (2009) Lucyna Kepka et al. Expert Review of Anticancer Therapy
- Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
- (2008) E. Schmidt et al. ANNALS OF ONCOLOGY
- Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
- (2008) John E. Levine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
- (2008) R. R. Jenq et al. BLOOD
- Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation
- (2008) R. M. Kelly et al. BLOOD
- Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients
- (2008) S Langner et al. BONE MARROW TRANSPLANTATION
- Palifermin in allogeneic HSCT: many questions remain
- (2008) W J F M van der Velden et al. BONE MARROW TRANSPLANTATION
- Prevalence of Outpatient Cancer Treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)
- (2008) Michael T. Halpern et al. CANCER INVESTIGATION
- Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma
- (2008) David M. Brizel et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started